A phase I dose escalating study of the angiogenesis inhibitor thrombospondin-1 mimetic (ABT-510) in patients with advanced cancer

被引：0
|
作者：
de Vos, FYFL
Hoekstra, R
Gietema, JA
Jager, PJ
Eskens, FALM
Carr, R
Guirguis, M
Humerickhouse, R
de Vries, EGE
Verweij, J
机构：
[1] Univ Groningen Hosp, Dept Med Oncol, Groningen, Netherlands
[2] Erasmus Univ, Med Ctr, Dept Med Oncol, Rotterdam, Netherlands
[3] Univ Groningen Hosp, Dept Nucl Med, Groningen, Netherlands
[4] Abbott Labs, Clin Pharmacokinet Dept, Abbott Pk, IL 60064 USA
[5] Abbott Labs, Dept Oncol, Abbott Pk, IL 60064 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2002年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
248
引用
收藏
页码：S78 / S79
页数：2
相关论文
共 50 条
  • [1] Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer
    Hoekstra, R
    de Vos, FYFL
    Eskens, FALM
    Gietema, JA
    van der Gaast, A
    Groen, HJM
    Knight, RA
    Carr, RA
    Humerickhouse, RA
    Verweij, J
    de Vries, EGE
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) : 5188 - 5197
  • [2] Randomized, Phase II Study of the Thrombospondin-1-Mimetic Angiogenesis Inhibitor ABT-510 in Patients With Advanced Soft Tissue Sarcoma
    Baker, Laurence H.
    Rowinsky, Eric K.
    Mendelson, David
    Humerickhouse, Rod A.
    Knight, Raymond A.
    Qian, Jiang
    Carr, Robert A.
    Gordon, Gary B.
    Demetri, George D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (34) : 5583 - 5588
  • [3] Phase I study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with 5-fluorouracil and leucovorin: A safe combination
    Hoekstra, R
    de Vos, FYFL
    Eskens, FALM
    de Vries, EGE
    Uges, DRA
    Knight, R
    Carr, RA
    Humerickhouse, R
    Verweij, J
    Gietema, JA
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (04) : 467 - 472
  • [4] A Phase 1 Trial of 2 Dose Schedules of ABT-510, an Antiangiogenic, Thrombospondin-1-mimetic Peptide, in Patients With Advanced Cancer
    Gordon, Michael S.
    Mendelson, David
    Carr, Robert
    Knight, Raymond A.
    Humerickhouse, Rod A.
    Iannone, Maria
    Stopeck, Alison T.
    CANCER, 2008, 113 (12) : 3420 - 3429
  • [5] A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumors
    Gietema, J. A.
    Hoekstra, R.
    de Vos, F. Y. F. L.
    Uges, D. R. A.
    van der Gaast, A.
    Groen, H. J. M.
    Loos, W. J.
    Knight, R. A.
    Carr, R. A.
    Humerickhouse, R. A.
    Eskens, F. A. L. M.
    ANNALS OF ONCOLOGY, 2006, 17 (08) : 1320 - 1327
  • [6] Prospective Study of Thrombospondin-1 Mimetic Peptides, ABT-510 and ABT-898, in Dogs with Soft Tissue Sarcoma
    Sahora, A. I.
    Rusk, A. W.
    Henkin, J.
    McKeegan, E. M.
    Shi, Y.
    Khanna, C.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2012, 26 (05): : 1169 - 1176
  • [7] A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma
    Markovic, Svetomir N.
    Suman, Vera J.
    Rao, Ravi A.
    Ingle, James N.
    Kaur, Judith S.
    Erickson, Lori A.
    Pitot, Henry C.
    Croghan, Gary A.
    McWilliams, Robert R.
    Merchan, Jaime
    Kottschade, Lisa A.
    Nevala, Wendy K.
    Uhl, Cindy B.
    Allred, Jacob
    Creagan, Edward T.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (03): : 303 - 309
  • [8] The Thrombospondin-1 Mimetic ABT-510 Increases the Uptake and Effectiveness of Cisplatin and Paclitaxel in a Mouse Model of Epithelial Ovarian Cancer
    Campbell, Nicole E.
    Greenaway, James B.
    Henkin, Jack
    Moorehead, Roger A.
    Petrik, Jim
    NEOPLASIA, 2010, 12 (03): : 275 - 283
  • [9] A phase 2 study of the thrombospondin-mimetic peptide ABT-510 in patients with refractory lymphoma.
    Levine, AM
    Schwartzberg, L
    Smith, S
    Belt, R
    Knight, R
    Carlson, D
    Hippensteel, R
    Kahl, B
    BLOOD, 2005, 106 (11) : 430A - 430A
  • [10] A randomized phase 2 study of the thrombospondin-mimetic peptide ABT-510 in patients with advanced soft tissue sarcoma (STS).
    Baker, LH
    Demetri, GD
    Mendelson, DS
    Rowinsky, EK
    McKeegan, EM
    Knight, RA
    Carlson, DM
    Lobell, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 819S - 819S
12345